Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocilizumab for the Treatment of Familial Mediterranean Fever (TOFFIFE)
2016-004505-13Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Familial Mediterranean fever (FMF) comparing Tocilizumab arm with Placebo arm (2 arms). Primary endpoint: Physician’s Global Assessment of disease activity at week 16. Started Aug 2017; status: completed.
02
Drugs
tocilizumab
03
Conditions
Familial Mediterranean fever (FMF)
Beyond the preview
Go deeper on 2016-004505-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004505-13.